Two cases of development of entecavir resistance during entecavir treatment for nucleoside-naive chronic hepatitis B-Reference-Cited by-同舟云学术

Two cases of development of entecavir resistance during entecavir treatment for nucleoside-naive chronic hepatitis B

Published:2008-12-09 Issue:2 Volume:3 Page:403-410
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Kobashi Haruhiko,Fujioka Shin-ichi,Kawaguchi Mitsuhiko,Kumada Hiromitsu,Yokosuka Osamu,Hayashi Norio,Suzuki Kazuyuki,Okanoue Takeshi,Sata Michio,Tsubouchi Hirohito,Sato Chifumi,Kiyosawa Kendo,Tanikawa Kyuichi,Seriu Taku,Ishikawa Hiroki,Takaki Akinobu,Iwasaki Yoshiaki,Osawa Toshiya,Takaki Toshiyuki,Sakaguchi Kosaku,Shiratori Yasushi,Yamamoto Kazuhide,Tenney Daniel J.,Omata Masao

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

http://link.springer.com/content/pdf/10.1007/s12072-008-9108-8.pdf

Reference28 articles.

1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004;11:97–107. doi: 10.1046/j.1365-2893.2003.00487.x

2. Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988;61:1942–1956. doi:10.1002/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J

3. Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006;295:65–73. doi: 10.1001/jama.295.1.65

4. Iloeje UH, Yang HI, Su J, et al. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 2006;130:678–686. doi: 10.1053/j.gastro.2005.11.016

5. Lai CL, Chien RN, Leung NW, Chang TT, Guan R, Tai DI, et al. A one year trial of lamivudine for chronic hepatitis B. N Engl J Med 1998;339:61–68. doi: 10.1056/NEJM199807093390201

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Entecavir resistance in a patient with treatment‑naïve HBV: A case report;Molecular and Clinical Oncology;2021-04-06

2. Combination therapy as an effective tool for treatment of drug-resistant viral infections;Combination Therapy Against Multidrug Resistance;2020

3. Switching to tenofovir vs continuing entecavir for hepatitis B virus with partial virologic response to entecavir: a randomized controlled trial;Journal of Viral Hepatitis;2018-06-06

4. Evolution of entecavir-resistant hepatitis B virus during entecavir and adefovir dipivoxil combination therapy;Experimental and Therapeutic Medicine;2015-11-12

5. A case of entecavir resistance which is developed after complete viral suppression during entecavir treatment for nucleoside-naive chronic hepatitis B;The Turkish Journal of Gastroenterology;2015-04-22